Micronics, Inc. (Micronics) has been awarded a Small Business Technology Transfer grant totaling approximately $440,000 to develop a rapid method for nucleic acid detection of known and emerging respiratory infections. The grant advances the combined use of two novel platforms for molecular diagnosis of these pathogens at low level and in a point of care test format.

The grant entails a collaborative effort between researchers at Micronics and the Seattle Children’s Research Institute (SCRI), in which a novel primer design method that enables detection of distantly related gene sequences will be used with Micronics’ microfluidic molecular diagnostic test platform.

Grant funding for this effort is from the National Institute of Allergy and Infectious Diseases under the National Institutes of Health (NIH), award number 1R43 AI084851-01.

Micronics is engaged in point of care tests for molecular detection of infectious diseases.